(Q34476154)

English

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia

scientific article

Statements

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia (English)
Maria Domenica Cappellini
Slaheddine Fattoum
Guillermo Drelichman
Miranda Athanassiou-Metaxa
Alexandra Kourakli-Symeonidis
Christiane Vermylen
Catherine Ressayre-Djaffer

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit